Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (727)	2/4/2004 1:13:01 AM
From: RWReeves	Read Replies (2) \| Respond to of 743

Buying: Funded ALTH and DOR at market close. D: I own neither in my personal account. I plan to liquidate CYAN and CVGR at tomorrow's close. CYAN has had a nice run but its a high cost producer in a market that just got price whacked by Chinese Phycos. Ouch. CVGR albeit an interesting company has not done much in all these years as with most CROs, and is being removed to make room for far more interesting game. RGEN has been doing well after the Ph III didn't meet its endpoints in Autism. My own belief is that it may work for some of the kids but not enough to convince the FDA. Need a tighter subgroup I think. D: I have some in the personal account and think I may add some here as raw speculative fodder on Secretin in Schizophrenia. RWR